Episode 26: SGLT-2 Inhibitors

Update: 2024-02-01

Description

Dr. Laura Hesemann, a med/peds-trained adult and pediatric nephrologist and Chair of Pediatrics at the University of Missouri, shares her expertise about SGLT-2 inhibitors and their utility in clinical practice.

Comments

In Channel

Episode 42: Chronic Hemodialysis Part 1

2025-10-0556:35

Episode 41: Atypical Hemolytic Uremic Syndrome

2025-09-0653:42

Episode 40: Hypertension Part 2

2025-08-0355:48

Episode 39: Hypertension Part 1

2025-07-0149:40

Episode 38: Congenital Anomalies of the Kidney and Urinary Tract- A Parent Perspective

2025-06-0550:51

Episode 37: Urinary Tract Infections

2025-05-1256:45

Episode 36: NephMadness 2025 Minimal Change Disease in Kids

2025-03-0944:57

Episode 35: Transition from Pediatric to Adult Care

2025-02-2047:23

Episode 34: Acute Kidney Injury

2025-01-0359:12

Episode 33: ARPKD

2024-12-0552:49

Episode 32: Kidney Health Monitoring in NICU Graduates

2024-11-0152:22

Episode 31: Genetic Testing

2024-10-0701:01:45

Episode 30: Anemia of Chronic Kidney Disease

2024-09-0646:23

Episode 29: Timing of Kidney Replacement Therapy

2024-06-0438:16

Episode 28: Calcium and phosphorus disorders

2024-04-0452:18

Episode 27: Hyperoxaluria and miscellaneous stone management

2024-03-1845:10

Episode 26: SGLT-2 Inhibitors

2024-02-0126:57

Episode 25: Pediatric dialysis directorship

2024-01-0447:02

Episode 24: Post-transplant FSGS Recurrence

2023-12-0439:03

Episode 23: Transplant Directorship

2023-11-1439:16

00:00

1.0x

Episode 26: SGLT-2 Inhibitors

#box-pro-ellipsis-175979106315648{-webkit-line-clamp:2;}Episode 26: SGLT-2 Inhibitors

Episode 26: SGLT-2 Inhibitors

zangl015

Episode 26: SGLT-2 Inhibitors